Report overview
The global Genetically Engineered Vaccines market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Genetic Recombinant Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Genetically Engineered Vaccines include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Sanofi, Zoties and Elanco, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Genetically Engineered Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Engineered Vaccines. This report contains market size and forecasts of Genetically Engineered Vaccines in global, including the following market information:
Global Genetically Engineered Vaccines Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Genetically Engineered Vaccines Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Genetically Engineered Vaccines companies in 2023 (%)
We surveyed the Genetically Engineered Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetically Engineered Vaccines Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Genetically Engineered Vaccines Market Segment Percentages, by Type, 2023 (%)
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Global Genetically Engineered Vaccines Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Genetically Engineered Vaccines Market Segment Percentages, by Application, 2023 (%)
Veterinary Use
Human Use
Global Genetically Engineered Vaccines Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Genetically Engineered Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genetically Engineered Vaccines revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Genetically Engineered Vaccines revenues share in global market, 2023 (%)
Key companies Genetically Engineered Vaccines sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Genetically Engineered Vaccines sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
GSK
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Walvax Biotechnology Co., Ltd.
Bharat Biotech
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant? Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genetically Engineered Vaccines, market overview.
Chapter 2: Global Genetically Engineered Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Genetically Engineered Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genetically Engineered Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Genetically Engineered Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
